This flavonol was shown to inhibit the growth of breast cancer stem cells, MCF-7, which are resistant to doxorubicine, through the down-regulation of P-gp expression, Y-box binding protein 1 (YB-1) nuclear protein, and the CD44+/CD24− phenotype [126]. The gene discussed is CD44; the disease is breast carcinoma.